Holen Sie sich die Stockscreener-App
63.48
2.47%
-1.61
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt CVS?
Forum
Prognose
Aktiensplit
Dividendenhistorie
Schlusskurs vom Vortag:
$65.09
Offen:
$62.88
24-Stunden-Volumen:
13.47M
Relative Volume:
1.06
Marktkapitalisierung:
$80.04B
Einnahmen:
$372.81B
Nettoeinkommen (Verlust:
$4.61B
KGV:
17.34
EPS:
3.66
Netto-Cashflow:
$6.33B
1W Leistung:
-3.57%
1M Leistung:
+19.44%
6M Leistung:
+8.85%
1J Leistung:
-17.72%
1-Tages-Spanne:
$62.02
$65.29
1-Wochen-Bereich:
$62.02
$67.17
52-Wochen-Spanne:
$43.56
$80.75
Cvs Health Corp Stock (CVS) Company Profile
Firmenname
Cvs Health Corp
Sektor
Branche
Telefon
(401) 765-1500
Adresse
ONE CVS DR., WOONSOCKET
Vergleichen Sie CVS mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
CVS
Cvs Health Corp
|
63.48 | 80.04B | 372.81B | 4.61B | 6.33B | 3.66 |
|
UNH
Unitedhealth Group Inc
|
466.42 | 429.24B | 400.28B | 14.41B | 20.71B | 15.50 |
|
ELV
Elevance Health Inc
|
385.10 | 89.31B | 176.81B | 5.98B | 4.55B | 25.60 |
|
CI
Cigna Group
|
299.81 | 82.08B | 244.32B | 3.43B | 5.18B | 12.24 |
|
HUM
Humana Inc
|
255.91 | 30.87B | 115.01B | 1.36B | -4.34B | 11.29 |
Cvs Health Corp Stock (CVS) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-02-13 | Hochstufung | Leerink Partners | Market Perform → Outperform |
| 2025-02-12 | Hochstufung | Cantor Fitzgerald | Neutral → Overweight |
| 2025-01-30 | Hochstufung | Edward Jones | Hold → Buy |
| 2024-12-03 | Hochstufung | Deutsche Bank | Hold → Buy |
| 2024-11-18 | Hochstufung | Wells Fargo | Equal Weight → Overweight |
| 2024-10-10 | Hochstufung | Barclays | Equal Weight → Overweight |
| 2024-10-04 | Hochstufung | TD Cowen | Hold → Buy |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Neutral |
| 2024-05-07 | Herabstufung | TD Cowen | Buy → Hold |
| 2024-05-02 | Herabstufung | UBS | Buy → Neutral |
| 2024-05-01 | Herabstufung | Cantor Fitzgerald | Overweight → Neutral |
| 2024-05-01 | Herabstufung | Leerink Partners | Outperform → Market Perform |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Eingeleitet | Leerink Partners | Outperform |
| 2023-12-22 | Eingeleitet | HSBC Securities | Buy |
| 2023-09-19 | Hochstufung | Evercore ISI | In-line → Outperform |
| 2023-09-12 | Hochstufung | Wolfe Research | Peer Perform → Outperform |
| 2023-08-18 | Herabstufung | Edward Jones | Buy → Hold |
| 2023-05-26 | Eingeleitet | Piper Sandler | Overweight |
| 2023-04-21 | Eingeleitet | Cantor Fitzgerald | Overweight |
| 2023-01-03 | Herabstufung | Evercore ISI | Outperform → In-line |
| 2022-11-23 | Fortgesetzt | Morgan Stanley | Overweight |
| 2022-06-17 | Eingeleitet | Loop Capital | Buy |
| 2022-05-27 | Herabstufung | Bernstein | Outperform → Mkt Perform |
| 2022-03-29 | Herabstufung | Deutsche Bank | Buy → Hold |
| 2022-02-11 | Herabstufung | Raymond James | Strong Buy → Outperform |
| 2021-12-14 | Eingeleitet | Goldman | Buy |
| 2021-12-01 | Eingeleitet | Seaport Research Partners | Buy |
| 2021-05-19 | Eingeleitet | Wells Fargo | Equal Weight |
| 2021-03-17 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-01-08 | Hochstufung | Jefferies | Hold → Buy |
| 2020-09-17 | Eingeleitet | Piper Sandler | Overweight |
| 2020-07-01 | Eingeleitet | SVB Leerink | Mkt Perform |
| 2020-05-14 | Hochstufung | Credit Suisse | Neutral → Outperform |
| 2019-09-27 | Fortgesetzt | RBC Capital Mkts | Outperform |
| 2019-09-12 | Eingeleitet | Deutsche Bank | Buy |
| 2019-06-05 | Hochstufung | Standpoint Research | Hold → Buy |
| 2019-04-29 | Herabstufung | Credit Suisse | Outperform → Neutral |
| 2019-04-18 | Eingeleitet | Guggenheim | Buy |
| 2019-04-15 | Herabstufung | Oppenheimer | Outperform → Perform |
| 2019-04-10 | Bestätigt | BofA/Merrill | Buy |
| 2019-03-13 | Eingeleitet | Bernstein | Outperform |
| 2019-02-20 | Herabstufung | Wells Fargo | Outperform → Market Perform |
| 2019-01-17 | Eingeleitet | UBS | Buy |
| 2018-12-18 | Eingeleitet | Barclays | Overweight |
| 2018-11-29 | Fortgesetzt | Goldman | Neutral |
| 2018-11-28 | Eingeleitet | Evercore ISI | Outperform |
| 2018-10-26 | Fortgesetzt | Wolfe Research | Peer Perform |
| 2018-07-09 | Hochstufung | Citigroup | Neutral → Buy |
| 2018-02-27 | Fortgesetzt | BofA/Merrill | Buy |
| 2018-02-13 | Bestätigt | Citigroup | Neutral |
Alle ansehen
Cvs Health Corp Aktie (CVS) Neueste Nachrichten
Capital City Trust Co. FL Sells 19,793 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Co. (NYSE:CVS) Shares Bought by Atria Wealth Solutions Inc. - MarketBeat
CVS Health: $97.7 Billion Revenue and a New CEO – Can It Overcome Industry Challenges? - Smartkarma
CVS Health Co. (NYSE:CVS) Position Reduced by Empower Advisory Group LLC - MarketBeat
New York State Common Retirement Fund Has $96.38 Million Stock Position in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Revamps Strategy As It Trims Employee Bonuses - Finimize
Davidson Investment Advisors Trims Stock Position in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS cuts bonuses after low profit levels in 2024 By Reuters - Investing.com
CVS Slashes Bonuses After 2024’s Profits Fell Short of Target - Bloomberg
CVS cuts bonuses after low profit levels in 2024 - Reuters.com
Citizens & Northern Corp Reduces Position in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Co. (NYSE:CVS) Director Acquires $2,001,000.00 in Stock - MarketBeat
CVS Health (NYSE:CVS) Shares Gap DownHere's Why - MarketBeat
Behind the Scenes of CVS Health's Latest Options Trends - Benzinga
DOJ Investigates UnitedHealth, Probe Accuses Of Inflating Medicare Diagnoses - Benzinga
Truist Financial Corp Sells 109,707 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Callahan Advisors LLC Has $1.31 Million Position in CVS Health Co. (NYSE:CVS) - MarketBeat
JPMorgan Chase & Co. Raises CVS Health (NYSE:CVS) Price Target to $81.00 - MarketBeat
Bernstein lifts CVS Health stock price target to $71 on Aetna outlook - Investing.com
Corps Capital Advisors LLC Invests $239,000 in CVS Health Co. (NYSE:CVS) - MarketBeat
Parthenon LLC Cuts Position in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Co. (NYSE:CVS) Stake Trimmed by Convergence Investment Partners LLC - MarketBeat
Allworth Financial LP Boosts Holdings in CVS Health Co. (NYSE:CVS) - MarketBeat
Principal Financial Group Inc. Decreases Position in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Co. (NYSE:CVS) Shares Sold by Sanctuary Advisors LLC - MarketBeat
L.M. Kohn & Company Has $265,000 Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Co. (NYSE:CVS) Holdings Boosted by Nations Financial Group Inc. IA ADV - MarketBeat
Allspring Global Investments Holdings LLC Sells 293,474 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
'Health insurance companies are always going to need a PBM': CVS president Prem Shah - Yahoo Canada Finance
Why CVS Health (CVS) Is Among the Best Performing Healthcare Stocks So Far in 2025 - Insider Monkey
Thermo Fisher appoints former CVS CEO to board - Investing.com
Former CVS Health CEO Karen Lynch Joins Thermo Fisher Scientific Board | CVS Stock News - StockTitan
CVS Health stock rises on director's $2M share purchase By Investing.com - Investing.com South Africa
CVS Health stock rises on director's $2M share purchase - Investing.com
CVS HEALTH Corp Director Michael F Mahoney Buys 30,000 Shares - TradingView
Cvs health director Michael Mahoney acquires $2m in stock - Investing.com
Judge Rejects Pharmacy Benefit Managers' Bid to Block FTC's Insulin Cost Case -February 19, 2025 at 11:11 am EST - Marketscreener.com
Drug Middlemen Lose Bid to Block FTC Case on Insulin Cost (1) - Bloomberg Law
Cantor Fitzgerald maintains CVS stock Overweight with $71 target - Investing.com
Plan Group Financial LLC Sells 4,697 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Some Investors May Be Willing To Look Past CVS Health's (NYSE:CVS) Soft Earnings - Yahoo Finance
Empowered Funds LLC Decreases Stake in CVS Health Co. (NYSE:CVS) - MarketBeat
CVS Health Surges Premarket As Q4 Earnings Blow Past Estimates, Retail Buzz Builds - MSN
Kentucky Retirement Systems Insurance Trust Fund Grows Stock Position in CVS Health Co. (NYSE:CVS) - MarketBeat
CIBC Asset Management Inc Acquires 4,967 Shares of CVS Health Co. (NYSE:CVS) - MarketBeat
Walgreens heeds warning, won't sell abortion pills in 20 states - The National Desk
CVS Group pres. explains PBMs' vital role in negotiating drug costs - Yahoo Finance
10 Health Care Stocks Whale Activity In Today's Session - Benzinga
CVS names longtime exec Ed DeVaney president of Caremark - Yahoo Finance
CVS names new chief executive for Caremark PBM division - The Business Journals
JPMorgan Chase & Co. Forecasts Strong Price Appreciation for CVS Health (NYSE:CVS) Stock - MarketBeat
Finanzdaten der Cvs Health Corp-Aktie (CVS)
Umsatz
Nettogewinn
Free Cashflow
ENV
0.04%
1.38%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):